Health Logic Interactive Inc. (CHYPF)
USD 0.04
(0.0%)
USD 0.04
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -60.69 Thousand USD | 89.85% |
| 2022 | -598.08 Thousand USD | 63.45% |
| 2021 | -1.63 Million USD | -464.94% |
| 2020 | -289.65 Thousand USD | -348.44% |
| 2019 | -64.59 Thousand USD | 90.73% |
| 2018 | -697.05 Thousand CAD | 65.41% |
| 2017 | -2.01 Million CAD | -61.99% |
| 2016 | -1.24 Million CAD | -72.8% |
| 2015 | -720.03 Thousand CAD | -150.83% |
| 2014 | -287.06 Thousand CAD | -12.93% |
| 2013 | -254.2 Thousand CAD | -18.68% |
| 2012 | -214.19 Thousand CAD | 6.76% |
| 2011 | -229.73 Thousand CAD | -990.68% |
| 2010 | -21.06 Thousand CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -20.46 Thousand CAD | -208.42% |
| 2024 Q1 | -6636.42 USD | 67.64% |
| 2023 Q4 | -20.5 Thousand USD | -17.16% |
| 2023 Q3 | -17.5 Thousand USD | 5.79% |
| 2023 Q1 | -3593.48 USD | 98.85% |
| 2023 FY | -60.69 Thousand USD | 89.85% |
| 2023 Q2 | -18.58 Thousand USD | -417.05% |
| 2022 Q2 | -83.85 Thousand CAD | 54.08% |
| 2022 Q1 | -182.61 Thousand CAD | 72.83% |
| 2022 FY | -598.08 Thousand USD | 63.45% |
| 2022 Q4 | -313.61 Thousand USD | -781.42% |
| 2022 Q3 | -35.58 Thousand USD | 57.57% |
| 2021 Q2 | -977.74 Thousand CAD | -292.53% |
| 2021 FY | -1.63 Million USD | -464.94% |
| 2021 Q1 | -249.09 Thousand CAD | 9.72% |
| 2021 Q4 | -672.04 Thousand CAD | -102.94% |
| 2021 Q3 | -331.15 Thousand CAD | 66.13% |
| 2020 Q4 | -275.9 Thousand CAD | -175.78% |
| 2020 Q3 | -100.04 Thousand CAD | -331.74% |
| 2020 Q1 | -19.19 Thousand CAD | 54.51% |
| 2020 FY | -289.65 Thousand USD | -348.44% |
| 2020 Q2 | -23.17 Thousand CAD | -20.74% |
| 2019 Q1 | -18.45 Thousand CAD | -101.3% |
| 2019 FY | -64.59 Thousand USD | 90.73% |
| 2019 Q4 | -42.18 Thousand CAD | -298.8% |
| 2019 Q3 | -10.57 Thousand CAD | 34.01% |
| 2019 Q2 | -16.03 Thousand CAD | 13.14% |
| 2018 FY | -697.05 Thousand CAD | 65.41% |
| 2018 Q4 | 1.41 Million CAD | 407.63% |
| 2018 Q3 | -460.99 Thousand CAD | 35.93% |
| 2018 Q2 | -719.54 Thousand CAD | 29.02% |
| 2018 Q1 | -1.01 Million CAD | 72.75% |
| 2017 Q1 | -456.99 Thousand CAD | -43.36% |
| 2017 Q3 | -521.02 Thousand CAD | 29.18% |
| 2017 FY | -2.01 Million CAD | -61.99% |
| 2017 Q2 | -735.72 Thousand CAD | -60.99% |
| 2017 Q4 | -3.72 Million CAD | -614.01% |
| 2016 Q4 | -318.77 Thousand CAD | 8.43% |
| 2016 Q2 | -431.49 Thousand CAD | 25.7% |
| 2016 Q1 | -580.77 Thousand CAD | -660.94% |
| 2016 FY | -1.24 Million CAD | -72.8% |
| 2016 Q3 | -348.12 Thousand CAD | 19.32% |
| 2015 Q2 | -252.52 Thousand CAD | -56.16% |
| 2015 Q4 | -76.32 Thousand CAD | 71.9% |
| 2015 Q3 | -271.57 Thousand CAD | -7.55% |
| 2015 FY | -720.03 Thousand CAD | -150.83% |
| 2015 Q1 | -161.71 Thousand CAD | -37.61% |
| 2014 Q3 | -15.18 Thousand CAD | 71.31% |
| 2014 Q2 | -52.94 Thousand CAD | 24.79% |
| 2014 Q1 | -70.39 Thousand CAD | 89.91% |
| 2014 FY | -287.06 Thousand CAD | -12.93% |
| 2014 Q4 | -117.51 Thousand CAD | -673.67% |
| 2013 Q3 | -40.65 Thousand CAD | 67.98% |
| 2013 FY | -254.2 Thousand CAD | -18.68% |
| 2013 Q1 | -23.96 Thousand CAD | 24.57% |
| 2013 Q2 | -126.96 Thousand CAD | -429.76% |
| 2013 Q4 | -697.88 Thousand CAD | -1616.69% |
| 2012 Q4 | -31.77 Thousand CAD | 14.45% |
| 2012 Q1 | -73.4 Thousand CAD | 16.37% |
| 2012 Q2 | -74.04 Thousand CAD | -0.86% |
| 2012 Q3 | -37.13 Thousand CAD | 49.84% |
| 2012 FY | -214.19 Thousand CAD | 6.76% |
| 2011 Q4 | -87.77 Thousand CAD | -44.09% |
| 2011 FY | -229.73 Thousand CAD | -990.68% |
| 2011 Q1 | -35.35 Thousand CAD | -162.17% |
| 2011 Q3 | -60.91 Thousand CAD | -33.34% |
| 2011 Q2 | -45.68 Thousand CAD | -29.23% |
| 2010 FY | -21.06 Thousand CAD | 0.0% |
| 2010 Q2 | -7.00 CAD | 0.0% |
| 2010 Q3 | -7571.00 CAD | -108057.14% |
| 2010 Q4 | -13.48 Thousand CAD | -78.11% |
| 2009 FY | - CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | 77.871% |
| IR-Med Inc. | -4.91 Million USD | 98.764% |
| Polarean Imaging plc | -12.55 Million USD | 99.517% |
| Medical Supply International USA, Inc. | 438.18 Thousand USD | 113.853% |
| Avitar, Inc. | 2.73 Million USD | 102.221% |
| AVITA Medical, Inc. | -40.4 Million USD | 99.85% |
| Manhattan Scientifics, Inc. | -703 Thousand USD | 91.366% |
| Össur hf. | 87.46 Million USD | 100.069% |
| Zecotek Photonics Inc. | -3.65 Million USD | 98.34% |
| QHSLab, Inc. | -240.15 Thousand USD | 74.725% |
| Wellstar International, Inc. | -1.79 Million USD | 96.618% |
| Össur hf. | 87.46 Million USD | 100.069% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 2.08 Million USD | 102.917% |
| Escalon Medical Corp. | -104.47 Thousand USD | 41.901% |
| Aurora Spine Corporation | -446.19 Thousand USD | 86.396% |
| BrainsWay Ltd. | -4.92 Million USD | 98.768% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -9.45 Million USD | 99.358% |
| Hamilton Thorne Ltd. | 277.99 Thousand USD | 121.834% |
| Vivos Inc. | -2.79 Million USD | 97.827% |
| MicroPort Scientific Corporation | -516.16 Million USD | 99.988% |
| Kelyniam Global, Inc. | -239.16 Thousand USD | 74.621% |
| REMSleep Holdings, Inc. | -1.77 Million USD | 96.574% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | 83.98% |
| Nanomix Corporation | -8.43 Million USD | 99.281% |
| Theraclion SA | -3.48 Million USD | 98.256% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -707.02 Thousand USD | 91.415% |
| Positron Corporation | -1.36 Million USD | 95.539% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -2.06 Million USD | 97.06% |
| Lombard Medical, Inc. | -29.33 Million USD | 99.793% |
| ALR Technologies Inc. | -2.94 Million USD | 97.94% |
| Stratec SE | 25.26 Million USD | 100.24% |
| Vycor Medical, Inc. | 40.19 Thousand USD | 251.026% |
| Heart Tronics, Inc. | 14.46 Million USD | 100.42% |
| Nu-Med Plus, Inc. | -120.52 Thousand USD | 49.638% |
| Perimeter Medical Imaging AI, Inc. | -20.72 Million USD | 99.707% |
| SANUWAVE Health, Inc. | -540 Thousand USD | 88.759% |
| VMS Rehab Systems, Inc. | -68.66 USD | -88305.185% |
| Guided Therapeutics, Inc. | -3.45 Million USD | 98.244% |
| Ingen Technologies, Inc. | -1.61 Million USD | 96.238% |
| Odyssey Group International, Inc. | 14.26 Million USD | 100.426% |
| United American Healthcare Corporation | -67 Thousand USD | 9.404% |
| ECGI Holdings, Inc. | -407.48 Thousand USD | 85.104% |
| Capital Group Holdings, Inc. | -634.68 Thousand USD | 90.436% |
| ADM Tronics Unlimited, Inc. | -601.52 Thousand USD | 89.909% |
| Urologix, Inc. | -6.93 Million USD | 99.124% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.26 Million USD | 95.195% |
| Nexeon MedSystems Inc. | -6.26 Million USD | 99.031% |
| SS Innovations International, Inc. | -20.66 Million USD | 99.706% |
| Qualis Innovations, Inc. | -230.24 Thousand USD | 73.637% |
| Smith & Nephew plc | 425 Million USD | 100.014% |
| NIOX Group Plc | 4.6 Million USD | 101.32% |
| Fuse Medical, Inc. | 383.82 Thousand USD | 115.814% |
| Broncus Holding Corporation | -33.22 Million USD | 99.817% |
| Brain Scientific Inc. | -9.6 Million USD | 99.368% |
| Pressure BioSciences, Inc. | -9.5 Million USD | 99.361% |